Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism

• Status: Completed
• Trial end date: 2016-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a clinical study comparing targeted levothyroxine dosing based on thyroid anatomy as visualized on ultrasound (normal vs. ectopic/sublingual vs. athyreosis) to empiric levothyroxine dosing in infants with congenital hypothyroidism. Patients enrolled in the study for targeted dosing will be compared to controls obtained by retrospective chart review. The main outcome is to determine if there is a difference in the frequency of over-treatment and under-treatment during the first 6 months of therapy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Erica Eugster

Criteria

Inclusion Criteria:

• Newborns diagnosed with congenital hypothyroidism (CH).

• Newborns with CH who are treated by a pediatric endocrinologist at Riley Hospital for Children or satellite location.

• Newborns with CH who have thyroid imaging performed (thyroid ultrasound or technetium scan) at diagnosis.

Exclusion Criteria:

• Newborns who do not have CH.

• Newborns with CH who have not had thyroid imaging performed at diagnosis.